Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63


Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.

Parris MS, Marver JE, Chaudhury SR, Ellis SP, Metts AV, Keilp JG, Burke AK, Oquendo MA, Mann JJ, Grunebaum MF.

Int Clin Psychopharmacol. 2018 Sep;33(5):249-254. doi: 10.1097/YIC.0000000000000225.


Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups.

Doshi S, Keilp JG, Strobino B, McElhiney M, Rabkin J, Fallon BA.

Psychosomatics. 2018 Mar 1. pii: S0033-3182(18)30131-2. doi: 10.1016/j.psym.2018.02.004. [Epub ahead of print]


Pathways to Late-Life Suicidal Behavior: Cluster Analysis and Predictive Validation of Suicidal Behavior in a Sample of Older Adults With Major Depression.

Szanto K, Galfalvy H, Vanyukov PM, Keilp JG, Dombrovski AY.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 17m11611. doi: 10.4088/JCP.17m11611.


Toward subtyping of suicidality: Brief suicidal ideation is associated with greater stress response.

Rizk MM, Galfalvy H, Singh T, Keilp JG, Sublette ME, Oquendo MA, Mann JJ, Stanley B.

J Affect Disord. 2018 Apr 1;230:87-92. doi: 10.1016/j.jad.2018.01.012.


The Data as It Is, and the Nature of Neurocognitive Difficulties in Post-Treatment Lyme Disease.

Keilp JG, Fallon BA.

Arch Clin Neuropsychol. 2017 Dec 13. doi: 10.1093/arclin/acx121. [Epub ahead of print] No abstract available.


Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.

Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ.

Am J Psychiatry. 2018 Apr 1;175(4):327-335. doi: 10.1176/appi.ajp.2017.17060647. Epub 2017 Dec 5.


Suicidal ideation declines with improvement in the subjective symptoms of major depression.

Keilp JG, Ellis SP, Gorlyn M, Burke AK, Oquendo MA, Mann JJ, Grunebaum MF.

J Affect Disord. 2018 Feb;227:65-70. doi: 10.1016/j.jad.2017.09.018. Epub 2017 Sep 19.


Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Vadhan NP, Corcoran CM, Bedi G, Keilp JG, Haney M.

Psychiatry Res. 2017 Nov;257:372-374. doi: 10.1016/j.psychres.2017.07.070. Epub 2017 Aug 1.


Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial.

Grunebaum MF, Ellis SP, Keilp JG, Moitra VK, Cooper TB, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ.

Bipolar Disord. 2017 May;19(3):176-183. doi: 10.1111/bdi.12487. Epub 2017 Apr 28.


Development, Administration, and Structural Validity of a Brief, Computerized Neurocognitive Battery.

Moore TM, Gur RC, Thomas ML, Brown GG, Nock MK, Savitt AP, Keilp JG, Heeringa S, Ursano RJ, Stein MB; Army STARRS Collaborators * .

Assessment. 2017 Jan 1:1073191116689820. doi: 10.1177/1073191116689820. [Epub ahead of print]


Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.

Mourik K, Decrescenzo P, Brucato G, Gill KE, Arndt L, Kimhy D, Keilp JG, Girgis RR.

Early Interv Psychiatry. 2017 Jun;11(3):250-254. doi: 10.1111/eip.12296. Epub 2015 Dec 10.


Further evidence of low baseline cortisol levels in suicide attempters.

Keilp JG, Stanley BH, Beers SR, Melhem NM, Burke AK, Cooper TB, Oquendo MA, Brent DA, John Mann J.

J Affect Disord. 2016 Jan 15;190:187-192. doi: 10.1016/j.jad.2015.10.012. Epub 2015 Oct 23.


Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior.

Melhem NM, Keilp JG, Porta G, Oquendo MA, Burke A, Stanley B, Cooper TB, Mann JJ, Brent DA.

Neuropsychopharmacology. 2016 May;41(6):1447-56. doi: 10.1038/npp.2015.309. Epub 2015 Oct 9.


A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.


Lateralization for speech predicts therapeutic response to cognitive behavioral therapy for depression.

Kishon R, Abraham K, Alschuler DM, Keilp JG, Stewart JW, McGrath PJ, Bruder GE.

Psychiatry Res. 2015 Aug 30;228(3):606-11. doi: 10.1016/j.psychres.2015.04.054. Epub 2015 Jun 11.


Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC.

Psychol Med. 2015 Oct;45(14):2959-73. doi: 10.1017/S0033291715000902. Epub 2015 Jun 4.


Social inference in individuals at clinical high risk for psychosis.

Gill KE, Cressman V, Poe SL, Steinfeld S, Ben-David S, Keilp JG, Moore H, Turkstra LS, Corcoran C.

Early Interv Psychiatry. 2016 Feb;10(1):77-80. doi: 10.1111/eip.12182. Epub 2014 Sep 9.


Neuropsychological deficits in past suicide attempters with varying levels of depression severity.

Keilp JG, Beers SR, Burke AK, Melhem NM, Oquendo MA, Brent DA, Mann JJ.

Psychol Med. 2014 Oct;44(14):2965-74. doi: 10.1017/S0033291714000786. Epub 2014 Apr 9.


Neurocognitive predictors of antidepressant clinical response.

Bruder GE, Alvarenga JE, Alschuler D, Abraham K, Keilp JG, Hellerstein DJ, Stewart JW, McGrath PJ.

J Affect Disord. 2014 Sep;166:108-14. doi: 10.1016/j.jad.2014.04.057. Epub 2014 May 4.


Intact alternation performance in high lethality suicide attempters.

Keilp JG, Wyatt G, Gorlyn M, Oquendo MA, Burke AK, John Mann J.

Psychiatry Res. 2014 Sep 30;219(1):129-36. doi: 10.1016/j.psychres.2014.04.050. Epub 2014 May 9.

Supplemental Content

Loading ...
Support Center